GIM
VRTX icon

Groesbeck Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Groesbeck Investment Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$730K Hold
1,470
– – 1.16% 23
2026
Q1 		$656K Buy
1,470
+111
+8% +$51.8K 1.28% 24
2025
Q4 		$616K Hold
1,359
– – 1.16% 28
2025
Q3 		$532K Sell
1,359
-500
-27% -$209K 1.04% 33
2025
Q2 		$828K Sell
1,859
-10
-0.5% -$4.61K 1.45% 27
2025
Q1 		$906K Hold
1,869
– – 1.27% 25
2024
Q4 		$753K Buy
1,869
+100
+6% +$46.4K 0.98% 33
2024
Q3 		$823K Sell
1,769
-25
-1% -$12K 1.21% 28
2024
Q2 		$841K Buy
1,794
+21
+1% +$9.12K 1.16% 31
2024
Q1 		$741K Hold
1,773
– – 0.79% 41
2023
Q4 		$721K Buy
1,773
+300
+20% +$111K 1% 34
2023
Q3 		$512K Buy
1,473
+240
+19% +$83.9K 0.78% 48
2023
Q2 		$434K Hold
1,233
– – 0.66% 51
2023
Q1 		$388K Hold
1,233
– – 0.58% 59
2022
Q4 		$356K Buy
1,233
+120
+11% +$36.6K 0.6% 57
2022
Q3 		$314K Hold
1,113
– – 0.52% 66
2022
Q2 		$314K Hold
1,113
– – 0.52% 66
2022
Q1 		$290K Hold
1,113
– – 0.32% 93
2021
Q4 		$244K Hold
1,113
– – 0.31% 84
2021
Q3 		$202K Sell
1,113
-50
-4% -$9.76K 0.23% 104
2021
Q2 		$234K Sell
1,163
-400
-26% -$83.7K 0.3% 85
2021
Q1 		$336K Hold
1,563
– – 0.48% 72
2020
Q4 		$369K Hold
1,563
– – 0.6% 61
2020
Q3 		$425K Buy
1,563
+13
+0.8% +$3.59K 0.8% 49
2020
Q2 		$450K Buy
+1,550
New +$420K 0.89% 48

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
AAIS
ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return

Groesbeck Investment Management's VRTX Position: Q2 2026 in Review

Groesbeck Investment Management held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2026 at 1,470 shares worth $730K. The position accounts for 1.16% of the portfolio, ranked #23.

Groesbeck Investment Management first reported a position in VRTX in Q2 2020 and has held it in 25 quarters since. The position peaked at $906K in Q1 2025. 484 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Groesbeck Investment Management held 1,470 shares of Vertex Pharmaceuticals worth $730K as of Q2 2026.
  • Groesbeck Investment Management left its Vertex Pharmaceuticals share count unchanged in Q2 2026.
  • Vertex Pharmaceuticals made up 1.16% of Groesbeck Investment Management's portfolio in Q2 2026, its #23 holding.
  • Groesbeck Investment Management first reported a position in Vertex Pharmaceuticals in Q2 2020 and has held it in 25 quarters since.
  • Groesbeck Investment Management's Vertex Pharmaceuticals position peaked at $906K in Q1 2025.
  • 484 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Groesbeck Investment Management's 13F filing for Q2 2026, filed 15 Jul 2026.